Aloe emodin decreases the ERK-dependent anticancer activity of cisplatin

Sanja Mijatović(University of Belgrade), Vladimir Trajković(University of Belgrade), Djordje Miljković(University of Belgrade), J. Radovic, Tibor J. Sabo(University of Belgrade), Danijela Maksimović‐Ivanić(Institute for Biological Research “Siniša Stanković”), Goran Kaludjerovic(University of Belgrade)
Cellular and Molecular Life Sciences
May 18, 2005
10.1007/s00018-005-5041-3
Cited by 68

Related Papers

Roles of the Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR pathways in controlling growth and sensitivity to therapy-implications for cancer and aging
|Aging|2011|707
Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR Inhibitors: Rationale and Importance to Inhibiting These Pathways in Human Health
|Oncotarget|2011|579
In vitro comparison of the photothermal anticancer activity of graphene nanoparticles and carbon nanotubes
|Biomaterials|2010|560
Biomedical potential of the reactive oxygen species generation and quenching by fullerenes (C60)
|Biomaterials|2008|463
Graphene quantum dots as autophagy-inducing photodynamic agents
|Biomaterials|2012|442